EUVIMEDEUVIMED entdecken
Crossref

L26/P-184 CRYOSTORAGE DURATION AND PREGNANCY OUTCOMES AFTER SINGLE EUPLOID EMBRYO TRANSFER

T. Alkon, C. Hernadez-Nieto, J.A. Lee, S. Kripalani, R. Zuho, M. Baird, V. Lazarov, M. Luna, A. Copperman, E. Buyuk

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Alkon und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does cryostorage duration compromise the reproductive potential of euploid blastocysts? Summary answer Implantation, clinical pregnancy and live births rates were comparable across cryostorage durations of single euploid embryo transfers (SEET). What is known already Prior studies concluded that prolonged blastocyst cryostorage, particularly beyond five years, was associated with reduced implantation and live birth rates. However, those findings relied on morphological score alone, which does not account for chromosomal competence. Euploid embryos identified by preimplantation genetic testing for aneuploidy (PGT-A) provide a standardized model for assessing the relationship between cryostorage duration and reproductive potential. As delayed embryo transfer becomes more common, data examining the relationship between cryostorage duration and pregnancy outcomes remain paramount for patients undergoing SEET. Study design, size, duration This retrospective cohort study was conducted at a private academic center and included all autologous IVF cycles with PGT-A performed using next-generation sequencing, followed by a SEET from January 2016 to June 2024. Embryos were vitrified, warmed, and transferred after varying periods of cryostorage. A total of 11,828 SEET cycles were analyzed. Power calculations indicated that 110 cycles per group were required to detect a 10% difference in live birth rates (α = 0.05). Participants/materials, setting, methods SEET cycles were stratified by cryostorage duration (≤3, 4–5, or ≥ 6 years), defined a priori based on thresholds commonly reported in prior literature. Primary outcome was live birth rate. Secondary outcomes included clinical, biochemical, and ectopic pregnancy and clinical pregnancy loss. Transfer cycles involving chromosomal rearrangements, monogenic testing, uterine factor infertility, recurrent pregnancy loss, or re-frozen embryos were excluded. Statistics included analysis of variance, chi-square testing, and multivariable logistic regression using generalized estimating equations. Main results and the role of chance A total of 11,828 SEET cycles met the inclusion criteria. Most cycles involved embryos cryostored for ≤3 years (n = 11,027; 93%), followed by 4–5 years (n = 647; 5.5%) and ≥6 years (n = 154; 1.5%). Live birth rates were comparable across cohorts (54.9%, 55.9%, and 54.7%, respectively; p = 0.79). No significant differences were observed in clinical pregnancy, biochemical pregnancy, ectopic pregnancy, or clinical pregnancy loss rates by cryostorage duration. On a multivariable logistic regression adjusting for age at oocyte retrieval and embryo transfer, body mass index, day of biopsy, and embryo quality at transfer, cryostorage duration was not associated with live birth (aOR 0.98; 95% CI 0.99–1.01). Similarly, no associations were observed for clinical pregnancy (aOR 1.00; 95% CI 0.98–1.05), ectopic pregnancy (aOR 0.99; 95% CI 0.99–1.03), biochemical pregnancy (aOR 1.00; 95% CI 0.99–1.03), or clinical pregnancy loss (aOR 0.99; 95% CI 0.99–1.01). Limitations, reasons for caution Given the retrospective design and potential differences in laboratory protocol(s) between the study site compared with external treatment centers, the generalizability of these findings may be limited. Wider implications of the findings Cryostorage duration was not associated with reproductive outcomes, providing reassurance regarding prolonged vitrification of euploid blastocysts prior a to SEET. These findings support patient counseling by indicating that delaying embryo transfer for personal, medical, or logistical reasons is not associated with adverse pregnancy outcomes. Trial registration number No

Zitieren

APA

Alkon, T., Hernadez-Nieto, C., Lee, J., Kripalani, S., Zuho, R., Baird, M., Lazarov, V., Luna, M., Copperman, A., & Buyuk, E. (2026). L26/P-184 CRYOSTORAGE DURATION AND PREGNANCY OUTCOMES AFTER SINGLE EUPLOID EMBRYO TRANSFER. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.520

Vancouver

Alkon T, Hernadez-Nieto C, Lee J, Kripalani S, Zuho R, Baird M, et al. L26/P-184 CRYOSTORAGE DURATION AND PREGNANCY OUTCOMES AFTER SINGLE EUPLOID EMBRYO TRANSFER. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.520

BibTeX
@article{Alkon2026,
  author = {Alkon, T. and Hernadez-Nieto, C. and Lee, J.A. and Kripalani, S. and Zuho, R. and Baird, M. and Lazarov, V. and Luna, M. and Copperman, A. and Buyuk, E.},
  title = {L26/P-184 CRYOSTORAGE DURATION AND PREGNANCY OUTCOMES AFTER SINGLE EUPLOID EMBRYO TRANSFER},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.520}
}
Kostenlos starten →